MARRONE BIO INNOVATIONS INC Contracts & Agreements

Agreement Relating to Restricted Stock Units, dated June 30, 2022 (Filed With SEC on June 30, 2022)

Reserve Shortfall Letter to Invoice Purchase Agreement, dated May 17, 2022 (Filed With SEC on May 19, 2022)

Description of Registrants Securities (Filed With SEC on March 30, 2022)

Agreement and Plan of Merger, dated as of March 16, 2022, by and among Bioceres Crop Solutions Corp., BCS Merger Sub, Inc., and Marrone Bio Innovations, Inc (Filed With SEC on March 16, 2022)

Amendment No. 1 dated as of December 30, 2021, to Amended Inventory Financing Addendum (Filed With SEC on January 6, 2022)

Offer letter, effective January 25, 2021, by and between Marrone Bio Innovations, Inc. and Suping Liu Cheung (Filed With SEC on January 29, 2021)

Change in Control Agreement, dated as of January 26, 2021, by and between Marrone Bio Innovations, Inc. and Suping Liu Cheung (Filed With SEC on January 29, 2021)

Amendment to the Van Herk Warrant, by and among, Marrone Bio Innovations, Inc., Ospraie Ag Science LLC, and Van Herk Investments B.V., dated December 29, 2020 (Filed With SEC on January 5, 2021)

Employment Separation Agreement, dated September 21, 2020 (Filed With SEC on September 23, 2020)

Consulting Agreement, dated September 21, 2020 (Filed With SEC on September 23, 2020)

Offer letter, dated July 3, 2020, by and between Marrone Bio Innovations, Inc. and Kevin Helash (Filed With SEC on July 6, 2020)

Change in Control Agreement, dated as of July 3, 2020, by and between Marrone Bio Innovations, Inc. and Kevin Helash (Filed With SEC on July 6, 2020)

Form of Warrant issuable pursuant to the Warrant Exchange Agreement (Filed With SEC on April 30, 2020)

Warrant Exchange Agreement dated as of April 29, 2020, by and among Marrone Bio Innovations, Inc., Ospraie Ag Science LLC, Ardsley Partners Renewable Energy Fund, L.P., National... (Filed With SEC on April 30, 2020)

Registration Rights Agreement, dated April 29, 2020, by and among Marrone Bio Innovations, Inc. and the investors named therein (Filed With SEC on April 30, 2020)

Promissory Note, dated April 13, 2020 by and between Five Star Bank and Marrone Bio Innovations, Inc (Filed With SEC on April 17, 2020)

Form of Warrants issued by Marrone Bio Innovations, Inc. in connection with June 2017 Consulting Agreement (Filed With SEC on March 16, 2020)

Description of Registrants Securities (Filed With SEC on March 16, 2020)

Employment Separation Agreement, dated December 1, 2019, between Marrone Bio Innovations, Inc. and Dr. Pamela G. Marrone (Filed With SEC on March 16, 2020)

Consulting Agreement, dated December 1, 2019, between Marrone Bio Innovations, Inc. and Dr. Pamela G. Marrone (Filed With SEC on March 16, 2020)

Amendment No. 2 dated as of January 7, 2020, to Invoice Purchase Agreement dated March 24, 2017 (Filed With SEC on January 9, 2020)

Amended Inventory Financing Addendum, dated as of January 6, 2020, to Invoice Purchase Agreement dated March 24, 2017 (Filed With SEC on January 9, 2020)

Asset Purchase Agreement dated September 10, 2019, by and among Austin Grant, Inc., Marrone Bio Innovations, Inc., and Bill Grant and Lucie Grant (Filed With SEC on November 19, 2019)

Amended lease agreement April 25, 2019 (Filed With SEC on August 8, 2019)

Warrant Amendment and Plan of Reorganization Agreement, dated August 6, 2019, by and among Marrone Bio Innovations, Inc., Ospraie AG Science LLC, Ardsley Partners Renewable Energy... (Filed With SEC on August 8, 2019)

Form of Warrant issuable pursuant to the Warrant Agreement (Filed With SEC on August 8, 2019)

Registration Rights Agreement, dated August 6, 2019, by and between Marrone Bio Innovations, Inc. and the investors named therein (Filed With SEC on August 8, 2019)

Share Purchase Agreement, dated August 7, 2019, by and among Marrone Bio Innovations, Inc., Pro Farm Technologies OY, the Shareholders and Matti Tiainen as Shareholders... (Filed With SEC on August 8, 2019)

Offer letter, dated April 16, 2018, between the Company and Kevin Hammill (Filed With SEC on August 14, 2018)

First Amendment to Invoice and Purchase Agreement, dated June 30, 2018, between the Company and LSQ Funding Group L.C (Filed With SEC on August 14, 2018)

Underwriting Agreement, dated April 18, 2018 (Filed With SEC on April 18, 2018)

Form of Warrants issued by Marrone Bio Innovations, Inc. pursuant to the Third Amendment to Loan Agreement, dated as of November 11, 2016, by and between Marrone Bio Innovations,... (Filed With SEC on April 5, 2018)

Fourth Amendment to Loan Agreement, dated as of October 12, 2017, by and between Marrone Bio Innovations, Inc. and Gordon Snyder, as agent (Filed With SEC on April 5, 2018)

Fifth Amendment to Loan Agreement, dated as of October 23, 2017, by and between Marrone Bio Innovations, Inc. and Gordon Snyder, as agent (Filed With SEC on April 5, 2018)

Omnibus Amendment No. 2, dated as of October 6, 2017, by and among Ivy Science & Technology Fund, Waddell & Reed Advisors Science & Technology Fund Ivy Funds VIP Science &... (Filed With SEC on April 5, 2018)

Omnibus Amendment No. 3, dated as of October 23, 2017, by and among Ivy Science & Technology Fund, Waddell & Reed Advisors Science & Technology Fund, Ivy Funds VIP Science &... (Filed With SEC on April 5, 2018)

Promissory Note, dated October 12, 2017, by and between Marrone Bio Innovations, Inc. and Dwight W. Anderson (Filed With SEC on April 5, 2018)

Amended and Restated Promissory Note, dated October 23 2017, by and between Marrone Bio Innovations, Inc. and Dwight W. Anderson (Filed With SEC on April 5, 2018)

Voting and Lock-Up Agreement, dated February 5, 2018, by and among the Ospraie Group, the Ardsley Group, the Waddell Group, Pamela G. Marrone and the Company (Filed With SEC on February 6, 2018)

Secured Promissory Note, dated as of December 22, 2017, between the Company and Dwight W. Anderson (Filed With SEC on December 29, 2017)

Security Agreement, dated as of December 22, 2017 between the Company and Dwight W. Anderson (Filed With SEC on December 29, 2017)

Form of SPA Warrants (Filed With SEC on December 18, 2017)

Form of Waddell Warrants (Filed With SEC on December 18, 2017)

Form of Snyder Warrants (Filed With SEC on December 18, 2017)

Form of NSC Warrants (Filed With SEC on December 18, 2017)

Letter Agreement dated August 15, 2017, by and between the Company and James B. Boyd (Filed With SEC on November 14, 2017)

MARRONE BIO INNOVATIONS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 14, 2017)

Exhibit 10.43 INTERCREDITOR AGREEMENT (Filed With SEC on May 15, 2017)

exhibit 10.44 invoice PURCHASE AGREEMENT (Filed With SEC on May 15, 2017)

SUBORDINATION AGREEMENT (Filed With SEC on May 15, 2017)

5,714,286 SHARES MARRONE BIO INNOVATIONS, INC. COMMON STOCK UNDERWRITING AGREEMENT (Filed With SEC on April 25, 2017)

CHANGE IN CONTROL AGREEMENT (Filed With SEC on April 3, 2017)

THIRD AMENDMENT TO LOAN AGREEMENT (Filed With SEC on April 3, 2017)

OMNIBUS AMENDMENT NO.1 TO NOTES (Filed With SEC on June 2, 2016)

2121 SecondStreet, Suite B-107 Davis, CA 95618 Phone: 530 ###-###-#### (Filed With SEC on November 10, 2015)

1540 DrewAvenue Davis, CA 95618 Phone: 530 ###-###-#### (Filed With SEC on November 10, 2015)

SENIOR SECURED PROMISSORY NOTE (Filed With SEC on August 25, 2015)

FORM OFWARRANT (Filed With SEC on August 25, 2015)

SECURITYAGREEMENT (Filed With SEC on August 25, 2015)

OMNIBUS AMENDMENTTO LOAN AGREEMENT (Filed With SEC on August 25, 2015)

SEPARATION AGREEMENT (Filed With SEC on August 25, 2015)

PROMISSORY NOTE (Filed With SEC on August 13, 2014)

[] Shares Marrone Bio Innovations, Inc. UNDERWRITING AGREEMENT (Filed With SEC on June 2, 2014)

2121 Second Street, Suite B-107 Davis, CA 95618 Phone: 530 ###-###-#### (Filed With SEC on May 15, 2014)

FIRST AMENDMENT TO LEASE (Filed With SEC on May 15, 2014)

LEASE BETWEEN MARRONE BIO INNOVATIONS, INC., a Delaware corporation AND SEVEN DAVIS, LLC, aDelaware limited liability company dated as of April 30, 2014 TABLE OF CONTENTS (Filed With SEC on May 15, 2014)

MARRONE BIO INNOVATIONS, INC. STOCK PURCHASE WARRANT WARRANT TO PURCHASE SHARES OF STOCK (Filed With SEC on March 25, 2014)

FORM OF WARRANT (Filed With SEC on March 25, 2014)

2121 Second Street, Suite B-107 Davis, CA 95618 Phone: 530 ###-###-#### (Filed With SEC on March 25, 2014)

TRANSITION AGREEMENT (Filed With SEC on March 25, 2014)

LEASE BETWEEN MARRONE BIO INNOVATIONS, INC., a Delaware corporation AND SIX DAVIS, LLC, aDelaware limited liability company September 9, 2013 TABLE OF CONTENTS (Filed With SEC on September 13, 2013)

LICENSE AGREEMENT (Filed With SEC on July 31, 2013)

COMMERCIAL AGREEMENT (Filed With SEC on July 31, 2013)

TECHNOLOGY EVALUATION AND MASTER DEVELOPMENT AGREEMENT (Filed With SEC on July 31, 2013)

[] Shares Marrone Bio Innovations, Inc. UNDERWRITING AGREEMENT (Filed With SEC on July 29, 2013)

MARRONE BIO INNOVATIONS, INC. 2013 STOCK INCENTIVE PLAN (Filed With SEC on July 22, 2013)

INDEMNIFICATION AGREEMENT (For Continuing Directors) (Filed With SEC on July 22, 2013)

MARRONE BIO INNOVATIONS, INC. SECOND AMENDED AND RESTATED INVESTORRIGHTS AGREEMENT (Filed With SEC on July 1, 2013)

MARRONE ORGANIC INNOVATIONS, INC., A DELAWARE CORPORATION Series A Preferred Stock Purchase Warrant (Filed With SEC on July 1, 2013)

MARRONE ORGANIC INNOVATIONS, INC. SERIES B PREFERRED STOCKPURCHASE WARRANT (Filed With SEC on July 1, 2013)

MARRONE BIO INNOVATIONS, INC. PREFERRED STOCK PURCHASE WARRANT (Filed With SEC on July 1, 2013)

MARRONE BIO INNOVATIONS, INC. STOCK OPTION PLAN (REPURCHASE PERMITTED) (Filed With SEC on July 1, 2013)

MARRONE BIO INNOVATIONS, INC. 2011 STOCK PLAN (Filed With SEC on July 1, 2013)

215 Madson Place, SuitesB/C Davis, CA 95618 ###-###-#### (Filed With SEC on July 1, 2013)

2121 Second Street, Suite B-107 Davis, CA95618 ###-###-#### (Filed With SEC on July 1, 2013)

2121 Second Street, Suite B-107 Davis, CA95618 ###-###-#### 2 (Filed With SEC on July 1, 2013)

AIR COMMERCIAL REAL ESTATE ASSOCIATION STANDARD MULTI-TENANT OFFICE LEASENET (Filed With SEC on July 1, 2013)

FIRST AMENDMENT TO LEASE (Filed With SEC on July 1, 2013)

SECOND AMENDMENT TO LEASE (Filed With SEC on July 1, 2013)

THIRD AMENDMENT TO LEASE (Filed With SEC on July 1, 2013)

FOURTH AMENDMENT TO LEASE (Filed With SEC on July 1, 2013)

FIFTH AMENDMENT TO LEASE (Filed With SEC on July 1, 2013)

SIXTH AMENDMENT TO LEASE (Filed With SEC on July 1, 2013)

MARRONE BIO INNOVATIONS, INC. CONVERTIBLE NOTE PURCHASEAGREEMENT (Filed With SEC on July 1, 2013)

AMENDMENT AND CONSENT (Filed With SEC on July 1, 2013)

LOAN AGREEMENT (Filed With SEC on July 1, 2013)

SECURITY AGREEMENT (Filed With SEC on July 1, 2013)

LOAN AGREEMENT (Filed With SEC on July 1, 2013)

SECURITY AGREEMENT (Filed With SEC on July 1, 2013)

NOTE PURCHASE AGREEMENT between MARRONE BIO INNOVATIONS, INC. and SYNGENTA VENTURES PTE. LTD. Dated as of December 6, 2012 NOTE PURCHASE AGREEMENT (Filed With SEC on July 1, 2013)

INTERCREDITOR AGREEMENT dated as of December 6, 2012, among MARRONE BIO INNOVATIONS, INC., as the Borrower, GORDON SNYDER, as Warrant Lender Agent, GORDON SNYDER, as Convertible... (Filed With SEC on July 1, 2013)

AMENDMENT AND CONSENT (Filed With SEC on July 1, 2013)

LICENSE AGREEMENT (Filed With SEC on July 1, 2013)

COMMERCIAL AGREEMENT (Filed With SEC on July 1, 2013)

TECHNOLOGY EVALUATION AND MASTER DEVELOPMENT AGREEMENT (Filed With SEC on July 1, 2013)

ASSET PURCHASE AGREEMENT (Filed With SEC on July 1, 2013)

CONVERTIBLE NOTE PURCHASE AGREEMENT (Filed With SEC on July 1, 2013)

CREDIT FACILITY AGREEMENT (Filed With SEC on July 1, 2013)

Category

Industry

Companies

Contracts

MARRONE BIO INNOVATIONS INC Contracts & Agreements